NO942720L - 1,5-benzobiazepinderivater og medisinsk anvendelse av disse - Google Patents

1,5-benzobiazepinderivater og medisinsk anvendelse av disse

Info

Publication number
NO942720L
NO942720L NO942720A NO942720A NO942720L NO 942720 L NO942720 L NO 942720L NO 942720 A NO942720 A NO 942720A NO 942720 A NO942720 A NO 942720A NO 942720 L NO942720 L NO 942720L
Authority
NO
Norway
Prior art keywords
benzobiazepine
derivatives
medical use
medical
benzobiazepine derivatives
Prior art date
Application number
NO942720A
Other languages
English (en)
Other versions
NO942720D0 (no
NO305952B1 (no
Inventor
Harry Finch
David Gordon Trist
Giorgio Tarzia
Aldo Feriani
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of NO942720D0 publication Critical patent/NO942720D0/no
Publication of NO942720L publication Critical patent/NO942720L/no
Publication of NO305952B1 publication Critical patent/NO305952B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO942720A 1992-01-21 1994-07-20 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater NO305952B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929201180A GB9201180D0 (en) 1992-01-21 1992-01-21 Chemical compounds
PCT/EP1993/000098 WO1993014074A1 (en) 1992-01-21 1993-01-19 1,5-benzodiazepine derivatives and their use in medicine

Publications (3)

Publication Number Publication Date
NO942720D0 NO942720D0 (no) 1994-07-20
NO942720L true NO942720L (no) 1994-07-20
NO305952B1 NO305952B1 (no) 1999-08-23

Family

ID=10708914

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942720A NO305952B1 (no) 1992-01-21 1994-07-20 1,5-benzodiazepinderivater, anvendelse derav og farmasoeytiske preparater

Country Status (29)

Country Link
US (2) US5580895A (no)
JP (1) JP3253723B2 (no)
KR (1) KR100263625B1 (no)
CN (1) CN1049217C (no)
AP (1) AP369A (no)
AU (2) AU3450193A (no)
BG (1) BG61876B1 (no)
CA (1) CA2087672C (no)
CZ (1) CZ283950B6 (no)
FI (1) FI111632B (no)
GB (1) GB9201180D0 (no)
GE (1) GEP20001968B (no)
HU (2) HU221297B1 (no)
IL (1) IL104447A (no)
IS (1) IS3970A (no)
MX (1) MX9300261A (no)
MY (1) MY131307A (no)
NO (1) NO305952B1 (no)
NZ (1) NZ245715A (no)
OA (1) OA09964A (no)
PH (1) PH30894A (no)
PL (1) PL175340B1 (no)
RO (1) RO114128B1 (no)
RU (1) RU2124009C1 (no)
SK (1) SK280173B6 (no)
TW (1) TW226013B (no)
UA (1) UA29416C2 (no)
WO (1) WO1993014074A1 (no)
ZA (1) ZA93375B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9225492D0 (en) * 1992-12-05 1993-01-27 Glaxo Group Ltd Amine derivatives
CN1120845A (zh) * 1993-04-15 1996-04-17 格拉克索有限公司 具有cck和/或胃泌素拮抗活性的1，5-苯并二氮杂䓬衍生物
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin
GB9308431D0 (en) * 1993-04-23 1993-06-09 Glaxo Spa Chemical compounds
GB9308421D0 (en) * 1993-04-23 1993-06-09 Glaxo Spa Chemical compounds
GB2280182A (en) * 1993-07-20 1995-01-25 Glaxo Spa Benzodiazepine derivatives
GB9314981D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
GB9315018D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
GB9314977D0 (en) * 1993-07-20 1993-09-01 Glaxo Spa Chemical compounds
DK0756602T3 (da) * 1994-04-14 2000-01-31 Glaxo Wellcome Inc CCK- eller gastrin-modulerende 5-heterocyclo-1,5-benzodiazepiner
US5739129A (en) * 1994-04-14 1998-04-14 Glaxo Wellcome Inc. CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
GB9420748D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc 1,5 benzodiazepine derivatives
US5780464A (en) * 1994-10-14 1998-07-14 Glaxo Wellcome Inc. Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
WO1997021731A1 (en) 1995-12-11 1997-06-19 New England Medical Center Hospitals, Inc. Assay for and uses of peptide hormone receptor ligands
US5750353A (en) * 1995-12-11 1998-05-12 New England Medical Center Hospitals, Inc. Assay for non-peptide agonists to peptide hormone receptors
DE69724644D1 (de) * 1996-12-10 2003-10-09 Zeria Pharm Co Ltd 1,5-benzodiazepinderivate
JP4613157B2 (ja) 2003-01-14 2011-01-12 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
GB0307918D0 (en) * 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
WO2005049024A2 (de) * 2003-11-18 2005-06-02 Boehringer Ingelheim International Gmbh Feste pharmazeutische zubereitungsform
AU2005264988B2 (en) 2004-06-17 2011-09-22 Cytokinetics, Inc. Substituted urea derivatives for treating cardiac diseases
US7538223B2 (en) 2005-08-04 2009-05-26 Cytokinetics, Inc. Compounds, compositions and methods
US20070161617A1 (en) 2005-12-15 2007-07-12 Morgan Bradley P Certain chemical entities, compositions and methods
US7825120B2 (en) 2005-12-15 2010-11-02 Cytokinetics, Inc. Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
WO2007078815A2 (en) 2005-12-16 2007-07-12 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
US7989455B2 (en) 2005-12-19 2011-08-02 Cytokinetics, Inc. Compounds, compositions and methods
CU20090172A7 (es) 2009-10-09 2011-10-05 Ct De Investigación Y Desarrollo De Medicamentos Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
ES2613808T3 (es) 2011-07-29 2017-05-26 Oncotherapy Science, Inc. Péptido derivado de ERAP1 y uso del mismo
CN103435562B (zh) * 2013-08-26 2016-02-24 华东理工大学 6-取代苯并二氮卓-2,4-二酮类化合物及其用途
NZ739226A (en) 2015-07-22 2022-11-25 Enanta Pharm Inc Benzodiazepine derivatives as rsv inhibitors
CN108699077B (zh) 2016-01-15 2021-03-02 英安塔制药有限公司 作为rsv抑制剂的杂环化合物
CN110809472B (zh) 2017-02-16 2023-05-23 英安塔制药有限公司 用于制备苯二氮䓬衍生物的方法
US10752598B2 (en) * 2017-06-07 2020-08-25 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as RSV inhibitors
WO2019006291A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
US11091501B2 (en) 2017-06-30 2021-08-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
US10881666B2 (en) 2017-09-29 2021-01-05 Enanta Pharmaceuticals, Inc. Combination pharmaceutical agents as RSV inhibitors
WO2019094920A1 (en) 2017-11-13 2019-05-16 Enanta Pharmaceuticals, Inc. Azepin-2-one derivatives as rsv inhibitors
WO2019199908A1 (en) 2018-04-11 2019-10-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
WO2020111167A1 (ja) 2018-11-30 2020-06-04 国立大学法人徳島大学 Ｂｉｇ３－ｐｈｂ２相互作用阻害ｐｈｂ２由来ペプチドを含む乳がん治療薬
WO2020190935A1 (en) 2019-03-18 2020-09-24 Enanta Pharmaceuticals, Inc. Benzodiazepine derivatives as rsv inhibitors
US11179400B2 (en) 2019-04-09 2021-11-23 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
US11534439B2 (en) 2020-07-07 2022-12-27 Enanta Pharmaceuticals, Inc. Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
US11945824B2 (en) 2020-10-19 2024-04-02 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
OA09964A (en) 1995-12-11
US5580895A (en) 1996-12-03
TW226013B (no) 1994-07-01
FI111632B (fi) 2003-08-29
MX9300261A (es) 1994-03-31
IL104447A (en) 1998-02-22
CA2087672C (en) 2003-08-05
ZA93375B (en) 1994-07-18
UA29416C2 (uk) 2000-11-15
GB9201180D0 (en) 1992-03-11
RU2124009C1 (ru) 1998-12-27
NO942720D0 (no) 1994-07-20
BG61876B1 (bg) 1998-08-31
HUT67375A (en) 1995-03-28
PH30894A (en) 1997-12-23
RU94037768A (ru) 1996-08-10
JPH07118244A (ja) 1995-05-09
JP3253723B2 (ja) 2002-02-04
KR100263625B1 (ko) 2000-11-01
CN1074678A (zh) 1993-07-28
FI943421A (fi) 1994-07-19
NZ245715A (en) 1995-07-26
IL104447A0 (en) 1993-05-13
GEP20001968B (en) 2000-03-05
HU9402150D0 (en) 1994-09-28
CA2087672A1 (en) 1993-07-22
AP9300478A0 (en) 1993-01-31
FI943421A0 (fi) 1994-07-19
AP369A (en) 1994-11-06
US5637697A (en) 1997-06-10
CN1049217C (zh) 2000-02-09
WO1993014074A1 (en) 1993-07-22
MY131307A (en) 2007-08-30
HU211295A9 (en) 1995-11-28
AU661749B2 (en) 1995-08-03
PL175340B1 (pl) 1998-12-31
SK280173B6 (sk) 1999-09-10
RO114128B1 (ro) 1999-01-29
HU221297B1 (en) 2002-09-28
CZ173694A3 (en) 1995-09-13
BG98881A (bg) 1995-03-31
NO305952B1 (no) 1999-08-23
CZ283950B6 (cs) 1998-07-15
AU3193593A (en) 1993-07-22
IS3970A (is) 1993-07-22
SK86494A3 (en) 1995-03-08
AU3450193A (en) 1993-08-03

Similar Documents

Publication Publication Date Title
NO942720D0 (no) 1,5-benzobiazepinderivater og medisinsk anvendelse av disse
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
NO953991D0 (no) Ultrasomisk og elektro-kirurgisk håndstykke av piezotype
IS3720A7 (is) Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun
DE59208263D1 (de) 3-Aryl-4-hydroxy-delta3-dihydrofuranon- und 3-Aryl-4-hydroxy-delta3-dihydrothiophenon-Derivate
NO943511L (no) Farmasöytiske preparater og anvendelse derav
DE69415163D1 (de) ZUZAMMENSETUNG ENTHALTEND 1,1,1,2,3,4,4,5,5,5,-DECAFLUORPENTAN UND n-PROPANOL
IS4481A (is) Díhýdrópyramídín og notkun þeirra
FI961599A (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
NO975439D0 (no) Ketonderivater og medisinsk anvendelse derav
NO307254B1 (no) 1,2,4-oksadiazolderivater og parasittbekjempningsmiddel inneholdende samme
EP0482649A3 (en) Cm-chitin derivatives and use thereof
FI931234A0 (fi) Foerfarande foer oevervakning av en patients tillstaond
DK0821692T3 (da) Immunopotenserende inosinmonophosphat-5'-nukleotidasemodstandsdygtige derivater og anvendelser deraf
DK0687728T3 (da) Reovirus stamme 2177 og vaccine indeholdende samme
IS4140A (is) Notkun á ferróseni og/eða ferrósenafleiðum
NO921086L (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
NO303392B1 (no) Polyetere, samt fremstilling og anvendelse av disse
ZA913171B (en) 1,5-benzothiazepinone derivatives,their preparations and pharmaceutical use
ZA92357B (en) Amide derivatives and their therapeutic use.
DE69226430D1 (de) Fungizide 4-thioxooxazolidin-2-one und 4-iminooxazolidin-2-one
NO905221D0 (no) Steriliseringsblandinger og anvendelse derav.
NO179907C (no) Benzokinoksaliner og farmasöytiske preparater inneholdende de samme
NO985572D0 (no) Substituerte amidinobenzenderivater og medisinske preparater derav
DK8690D0 (da) Forbindelser og anvendelse